ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS. Mediterr J Hematol Infect Dis [Internet]. 2012 Nov. 6 [cited 2026 Apr. 18];4(1):e2012072. Available from: https://www.mjhid.org/mjhid/article/view/2012.072